ASX Share rice
Fri 14 Aug 2020 - 12:55:pm (Sydney)

CGB Share Price

CANN GLOBAL LIMITEDCGBPharmaceuticals, Biotechnology & Life Sciences

CGB Company Information

Name:

Cann Global Limited

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Address:

24 Birriga Road Bellevue Hill Australia 2023

Phone:

61 2 8379 1832

Exec. Chairperson & Exec. Director of Bus. Devel.:

Ms. Pnina Feldman

CEO, MD & Exec. Director:

Mr. Sholom Dovber Feldman

Exec. Director:

Mr. Andrew Kavasilas

Company Sec.:

Mr. Alexander James Neuling A.C.I.S., B.Sc., F.C.A., BSc, FCA (ICAEW), ACIS

Company Overview:

Cann Global Limited operates in medicinal cannabis and hemp industries in Australia and internationally. It grows and cultivates hemp and medical cannabis products. The company also engages in the exploration and development of bauxite. In addition, the company holds interests in the South Johnstone Project located in Queensland; and the New England Bauxite Project located in the New South Wales. The company has a strategic alliance with Bio Health Pharmaceuticals Pty Limited. The company was formerly known as Queensland Bauxite Limited and changed its name to Cann Global Limited in January 2019. The company was incorporated in 2007 and is based in Bellevue Hill, Australia.

CGB Share Price Information

Shares Issued:

3.86B

Market Capitalisation:

$19.30M

Revenue (TTM):

$873.13K

Earnings per Share:

$-0.004

Operating Margin (TTM):

$-6.15

Return On Assets (TTM):

$-0.23

Return On Equity (TTM):

$-1.09

Quarterly Revenue Growth (YOY):

1.29

Gross Profit(TTM):

$-81,571

Diluted Earnings Per Share (TTM):

$-0.003

CGB CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-399,856

Change To Liabilities:

$662.50K

Total Cashflow From Investing Activities:

$-399,856

Net Borrowings:

$3.61M

Net Income:

$-6,434,935

Total Cash From Operating Activities:

$-3,871,089

Depreciation:

$45.53K

Change To Inventory:

$395.13K

Change To Account Receivables:

$-236,935

Capital Expenditures:

$399.86K

CGB Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-9,234,372

Net Income:

$-6,434,935

Gross Profit:

$-81,571

Operating Income:

$-5,443,696

Other Operating Expenses:

$132.11K

Interest Expense:

$0.91M

Total Revenue:

$480.65K

Total Operating Expenses:

$5.36M

Cost Of Revenue:

$562.22K

CGB Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$193.05K

Total Liabilities:

$7.95M

Total Stockholder Equity:

$5M

Other Current Liabilities:

$292.67K

Total Assets:

$10.83M

Common Stock:

$29.60M

Retained Earnings:

$-29,858,406

Good Will:

$1.73M

Cash:

$5.18M

Total Current Liabilities:

$7.95M

Short-Term Debt:

$6.41M

Property - Plant & Equipment:

$2.31M

Net Tangible Assets:

$3.08M

Long-Term Investments:

$210.97K

Total Current Assets:

$6.39M

Net Receivables:

$7.25K

Short-Term Investments:

$4.44M

Inventory:

$168.86K

Accounts Payable:

$1.18M

Non Currrent Assets (Other):

$4.44M

Short-Term Investments:

$4.44

Non Current Liabilities Total:

$0

CGB Share Price History

CGB News

09 Mar, 2020
In 2007 Sholom Feldman was appointed CEO of Cann Global Limited (ASX:CGB). This analysis aims first to contrast CEO...
20 Oct, 2019
If you want to know who really controls Cann Global Limited (ASX:CGB), then you'll have to look at the makeup of its...